Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Outcomes, outcomes, every where, nor any stop to think?

Literature DB >> 21901493

Outcomes, outcomes, every where, nor any stop to think?

Colin P West.

Abstract

Mesh：

Year: 2011 PMID： 21901493 PMCID： PMC3208459 DOI： 10.1007/s11606-011-1852-0

Source DB: PubMed Journal: J Gen Intern Med ISSN： 0884-8734 Impact factor: 5.128

Keyword Cloud
References

× No keyword cloud information.

15 in total

1. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group.

Authors: H C Bucher; G H Guyatt; D J Cook; A Holbrook; F A McAlister
Journal: JAMA Date: 1999-08-25 Impact factor: 56.272

2. Reporting number needed to treat and absolute risk reduction in randomized controlled trials.

Authors: Jim Nuovo; Joy Melnikow; Denise Chang
Journal: JAMA Date: 2002-06-05 Impact factor: 56.272

3. Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors: Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal: JAMA Date: 2003-05-21 Impact factor: 56.272

Review 4. Users' guide to detecting misleading claims in clinical research reports.

Authors: Victor M Montori; Roman Jaeschke; Holger J Schünemann; Mohit Bhandari; Jan L Brozek; P J Devereaux; Gordon H Guyatt
Journal: BMJ Date: 2004-11-06

Review 5. Validity of composite end points in clinical trials.

Authors: Victor M Montori; Gaietà Permanyer-Miralda; Ignacio Ferreira-González; Jason W Busse; Valeria Pacheco-Huergo; Dianne Bryant; Jordi Alonso; Elie A Akl; Antònia Domingo-Salvany; Edward Mills; Ping Wu; Holger J Schünemann; Roman Jaeschke; Gordon H Guyatt
Journal: BMJ Date: 2005-03-12

6. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.

Authors: Paul M Ridker; Jose Torres
Journal: JAMA Date: 2006-05-17 Impact factor: 56.272

Outcomes, outcomes, every where, nor any stop to think?

1. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group.

2. Reporting number needed to treat and absolute risk reduction in randomized controlled trials.

3. Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Review 4. Users' guide to detecting misleading claims in clinical research reports.

Review 5. Validity of composite end points in clinical trials.

6. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.

7. Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks.

Review 8. Surrogate end points in clinical trials: are we being misled?

9. Endpoint selection and relative (versus absolute) risk reporting in published medication trials.

10. Why most published research findings are false.